Glutathione reduced ethyl ester
CAS: 118421-50-4
Ref. 3D-FG03344
1g | 693.00 € | ||
2g | 1,071.00 € | ||
5g | 2,142.00 € | ||
250mg | 297.00 € | ||
500mg | 450.00 € |
Product Information
- GSH-MEE Glutathione Monoethyl Ester gamma-Glu-Cys-Gly-OEt
- Glutathione monoethyl ester
- Glycine, <span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl-, monoethyl ester
- Glycine, N-(N-<span class="text-smallcaps">L</smallcap>-γ-glutamyl-<smallcap>L</span>-cysteinyl)-, monoethyl ester
- Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-, monoethyl ester
- Ione Ethyl Ester
- N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine monoethyl ester
- ethyl L-gamma-glutamyl-L-cysteinylglycinate
- Glycine, N-(N-L-γ-glutamyl-L-cysteinyl)-, monoethyl ester
- Glycine, L-γ-glutamyl-L-cysteinyl-, monoethyl ester
- See more synonyms
Glutathione reduced ethyl ester (GR-E) is a potential anticancer drug that binds to the DNA and induces reactive oxygen species. GR-E has been shown to have minimal toxicity in vivo, with no observable adverse effects on the liver. GR-E has also been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has been shown to be effective in treating squamous cell carcinoma cells by binding to their DNA and inducing apoptosis. This drug had minimal toxicity in animal studies, with no observable adverse effects on the liver. GR-E has also been shown to bind to toll-like receptor 2, which may lead to an antiinflammatory response.
Chemical properties
Technical inquiry about: 3D-FG03344 Glutathione reduced ethyl ester
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.